Cubist Systematic Strategies’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,904
Closed -$1.75M 2617
2020
Q1
$1.75M Sell
9,904
-26,196
-73% -$4.93M 0.05% 527
2019
Q4
$6.9M Buy
36,100
+23,913
+196% +$4.31M 0.13% 196
2019
Q3
$2.05M Buy
12,187
+7,330
+151% +$1.19M 0.04% 611
2019
Q2
$813K Sell
4,857
-21,527
-82% -$2.98M 0.01% 1156
2019
Q1
$3.86M Buy
26,384
+19,758
+298% +$2.86M 0.13% 204
2018
Q4
$886K Buy
6,626
+6,026
+1,004% +$988K 0.04% 627
2018
Q3
$114K Sell
600
-5,961
-91% -$1.1M 0.01% 1582
2018
Q2
$1.09M Buy
6,561
+4,199
+178% +$674K 0.05% 446
2018
Q1
$398K Sell
2,362
-10,036
-81% -$1.68M 0.02% 965
2017
Q4
$2.03M Buy
12,398
+3,667
+42% +$658K 0.11% 225
2017
Q3
$1.79M Buy
8,731
+7,335
+525% +$1.71M 0.1% 201
2017
Q2
$339K Sell
1,396
-5,304
-79% -$1.25M 0.02% 957
2017
Q1
$1.6M Sell
6,700
-3,449
-34% -$803K 0.11% 195
2016
Q4
$2.13M Buy
10,149
+1,925
+23% +$399K 0.17% 131
2016
Q3
$1.89M Buy
8,224
+4,111
+100% +$1M 0.12% 216
2016
Q2
$950K Sell
4,113
-31,154
-88% -$7.18M 0.06% 466
2016
Q1
$9.45M Buy
35,267
+30,417
+627% +$8.71M 0.54% 10
2015
Q4
$1.52M Sell
4,850
-9,071
-65% -$2.7M 0.09% 311
2015
Q3
$3.78M Sell
13,921
-40,031
-74% -$12.3M 0.19% 80
2015
Q2
$16.4M Buy
53,952
+16,809
+45% +$5.01M 0.8% 2
2015
Q1
$11.1M Buy
37,143
+6,700
+22% +$1.91M 0.54% 4
2014
Q4
$7.84M Buy
30,443
+29,634
+3,663% +$7.41M 0.42% 17
2014
Q3
$195K Sell
809
-17,932
-96% -$4.01M 0.01% 1389
2014
Q2
$4.18M Buy
+18,741
New +$3.88M 0.25% 72

Other funds holding AGN

Cubist Systematic Strategies's AGN Position: Q2 2020 in Review

Cubist Systematic Strategies sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,904 shares — an estimated $1.75M sold.

Cubist Systematic Strategies first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $16.4M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Cubist Systematic Strategies reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Cubist Systematic Strategies sold 9,904 Allergan plc shares in Q2 2020, an estimated $1.75M.
  • Cubist Systematic Strategies first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Cubist Systematic Strategies's Allergan plc position peaked at $16.4M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Cubist Systematic Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.